<?xml version="1.0" encoding="UTF-8"?>
<p id="Par20">In total, 50 patients (median age, 61 years old; range, 46–86 years old) from March 2015 to November 2016 were enrolled. Median follow-up was 37 months. Of these patients, 33 patients were performed HIPEC with cisplatin, the others underwent adjuvant SOX regime alone. Patients in this study were well balanced and comparable regarding baseline clinic-pathological parameters (
 <italic>P</italic> &gt; 0.05; Table 
 <xref rid="Tab1" ref-type="table">1</xref>). 
</p>
